HAORUI PRECISION INSTRUMENTS CO., LTD

Executive Summary

HAORUI PRECISION INSTRUMENTS CO., LTD currently exhibits financial dormancy with no operational activity or income generation, reflected in a stable but inactive balance sheet. While there are no signs of financial distress, the company's future viability depends on transitioning from dormancy to active trading and cash flow management. Immediate focus on business activation and financial monitoring is recommended to restore financial vitality.

HAORUI PRECISION INSTRUMENTS CO., LTD - Analysis Report

Company Number: 14215376

Analysis Date: 2025-07-19 12:04 UTC

Financial Health Assessment for HAORUI PRECISION INSTRUMENTS CO., LTD

---

1. Financial Health Score: D

Explanation:
The company is essentially dormant, with no trading activity or financial transactions reported for the fiscal year ending 31 July 2023. While it has a positive net asset position (£50,000 in share capital), the absence of operational data and revenue generation is a significant concern for financial vitality. Dormancy suggests the company is currently in a state of financial rest rather than active growth or distress.

---

2. Key Vital Signs

Vital Sign	Value	Interpretation
Status	Active	Company is legally active but dormant accounts filed, indicating no trading activity.
Net Assets	£50,000	Positive equity, reflecting initial share capital invested; no liabilities reported.
Shareholders' Funds	£50,000	Entirely represented by share capital; no retained earnings or operational profit/loss.
Financial Activity	Dormant	No income, expenses, or cash flow; no financial transactions in the reported period.
Filing Compliance	Up to date	Accounts and confirmation statements filed on time, showing good administrative discipline.
Industry Classification (SIC)	Agents sales, repair, manufacture (46190, 46140, 33190, 26511)	Diverse potential business sectors but currently inactive.

---

3. Diagnosis: Financial "Health" Status

The company's financial "vital signs" reveal a business in a dormant state, akin to a patient in clinical remission—stable but not actively engaging in business metabolism. The balance sheet is clean and simple, with the £50,000 share capital fully intact and no liabilities or operational results to report. This suggests a "symptom of rest" rather than distress, but also a lack of growth or cash flow generation.

From a business health perspective:

• Lack of income generation and cash flow: The company is not generating revenue or incurring expenses, meaning it is not currently contributing to operational markets or expanding.
• Absence of financial risks: No debts or liabilities are present, so financial distress symptoms such as over-leverage or liquidity crunch are not evident.
• Potential for activation: The company holds a foundation of capital and legal status to begin trading but has yet to do so.

Overall, the company is in a "quiescent" state, neither thriving nor deteriorating financially.

---

4. Recommendations: Prescriptions for Financial Wellness

1. Activate Business Operations:
   To shift from dormancy to a healthy growth phase, management should develop and implement a clear business plan aimed at generating revenue and cash flow. Dormancy is sustainable short-term but non-viable as a long-term business model.

2. Monitor and Manage Cash Flow:
   Once trading begins, close attention to cash flow management will be critical to avoid financial "symptoms" such as cash shortages or delayed payments.

3. Regular Financial Reporting:
   Maintain timely filings and consider producing management accounts to monitor financial "vital signs" more frequently than annual statutory accounts.

4. Strategic Use of Capital:
   Utilize the £50,000 equity base efficiently — invest in operational assets, marketing, or product development to stimulate business activity.

5. Engage Professional Advice:
   Seek guidance on market positioning and financial structuring to improve funding, profitability, and sustainability.

---